Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1Infections 1

Interventions

Voriconazole 4Vancomycin 3Fluconazole 3Filgrastim 3Ciprofloxacin 3Caspofungin 3liposomal amphotericin B 2Trimethoprim, Sulfamethoxazole Drug Combination 2Therapeutics 2Piperacillin, Tazobactam Drug Combination 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Itraconazole 2Granulocyte Colony-Stimulating Factor 2Fosfomycin 2Daptomycin 2Cyclophosphamide 2Cefazolin 2Antibiotic Prophylaxis 2ziprasidone 1threonic acid 1telavancin 1soybean oil, phospholipid emulsion 1plerixafor 1monalizumab 1lime 1human papillomavirus vaccine, L1 type 16, 18 1fluorescein isothiocyanate-keyhole limpet hemocyanin 1fludarabine phosphate 1fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Infections × Trimethoprim × Clear all
NCT00002850 2015-11-11

Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy

University of Rochester

Phase 3 Completed
212 enrolled 12 charts
Plasma cell

Infections, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡